mProX™ Human CDC7 Stable Cell Line
- Product Category:
- Membrane Protein Stable Cell Lines
- Subcategory:
- Kinase Cell Lines
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
Made to Order Inquiry
InquiryProduct Information
Product Properties
Protocols
Please visit our protocols page.
Customer Reviews
Charles
Verified Customer
Emily
Verified Customer
Any questions about our products? Please visit our frequently asked questions page.
Published Data
Fig.1 Combined CDC7 and ATR-CHK1 inhibition leads to defective cell cycle of HCC cells.
Typical live cell pictures of GFP-Histone 2B-expressing PLC/PRF/5 and SNU449 cells. Time-lapse microscopy was used to track cells treated with XL413 (10 μM), AZD6738 (1.25 μM), MK-8776 (2.5 μM), or the indicated combinations.
Ref: Guo, Yuchen, et al. "Targeting CDC7 potentiates ATR-CHK1 signaling inhibition through induction of DNA replication stress in liver cancer." Genome Medicine 13.1 (2021): 1-15.
Pubmed: 34663432
DOI: 10.1186/s13073-021-00981-0
Research Highlights
Chemotherapeutic medicines that target replication stress (RS), a hallmark of cancer, are commonly utilized to treat a variety of malignancies. The development of next-generation anticancer medicines that induce replication stress (RS) has focused on cell division cycle 7 (CDC7) as a target.
Iwai, Kenichi, et al. "Molecular mechanism and potential target indication of TAK-931, a novel CDC7-selective inhibitor." Science advances 5.5 (2019): eaav3660.
Pubmed:
31131319
DOI:
10.1126/sciadv.aav3660
These data challenge our knowledge of how the cell cycle proceeds by showing that, while CDC7 serves a redundant role in DNA replication, CDK1 physiologically controls two different transitions during the cell division cycle.
Suski, Jan M., et al. "CDC7-independent G1/S transition revealed by targeted protein degradation." Nature 605.7909 (2022): 357-365.
Pubmed:
35508654
DOI:
10.1038/s41586-022-04698-x